Cure My Disease

Don't miss your cure!

 Log in / Sign up

Electric field therapy plus immunotherapy tested for tough lung cancers

NCT ID NCT06558799

Terminated Disease control Sponsor: NovoCure GmbH Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a wearable device that sends low-intensity electric fields to tumors, combined with the immunotherapy drug pembrolizumab, in people with advanced non-small cell lung cancer that had already been treated with chemotherapy and immunotherapy. The goal was to see if this combination could help patients live longer. The study was stopped early, and only 31 people took part.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER (NSCLC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Neoplasm Metastasis non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NON-SMALL CELL LUNG CANCER (NSCLC)

Contacts and locations

Locations

  • AO SM Misericordia di Perugia

    Perugia, 06129, Italy

  • AOUS Policlinico Le Scotte U.O.C. Immunoterapia Oncologica

    Siena, 53100, Italy

  • APHP - Hôpital Ambroise-Paré

    Boulogne-Billancourt, 92100, France

  • Centre Hospitalier Intercommunal de Cornouaille Service D'oncologie Médicale

    Quimper, 29107, France

  • Centre Léon Berard Service D'oncologie Médicale

    Lyon, 69373, France

  • Centre hospitalier intercommunal de Créteil Service de Pneumologie

    Créteil, 94010, France

  • Clínica Universidad de Navarra

    Pamplona, 31008, Spain

  • Clínica Universidad de Navarra, Madrid

    Madrid, 28027, Spain

  • FN Motol

    Prague, 150 06, Czechia

  • General University Hospital in Prague, Clinic of Oncology

    Prague, 128 08, Czechia

  • Hospital Regional Universitario de Malaga (Hospital Civil)

    Málaga, Spain

  • Hospital Universitario Arnau de Vilanova

    Lleida, Spain

  • Hospital Universitario Virgen del Rocio

    Seville, Spain

  • Hospital Universitario del Vinalopó

    Elche, 03293, Spain

  • Humanitas Gavazzeni Bergamo-U.O.Farmacia-Edificio D Piano -1

    Bergamo, Italy

  • Hôpital Européen Marseille

    Marseille, 13003, France

  • Hôpital Privé du Confluent Service D'oncologie Médicale

    Nantes, 44277, France

  • Istituto Europeo di Oncologia

    Milan, 20141, Italy

  • MS Pneumed Janusz Milanowski, Katarzyna Szmygin-Milanowska Spó?ka Jawna

    Lublin, Poland

  • Montpellier University Hospital

    Montpellier, 34295, France

  • Pratia MCM Kraków

    Krakow, Poland

  • Rijnstate Ziekenhuis

    Arnhem, Netherlands

  • Universitätsklinik f. Innere Medizin III

    Salzburg, Austria

  • Vitkovicka Nemocnice

    Ostrava, 1192, Czechia

More trials for these conditions

Other studies related to the condition(s) this trial covers.